Mission
Accelerate the global growth of Ukrainian defence-tech, dual-use, and health-tech ventures
Who We Are
Why Obriy? - Our Strategic Edge
Addressing ongoing challenges for the Ukrainian Tech:
Limited visibility with primes & agencies
Fragmented U.S. regulations (ITAR/EAR, FDA, HIPAA, etc.)
Obriy Solution: One-stop regulatory playbooks & filings.Resulting Advantage: Faster clearance, lower compliance cost.
Ownership restrictions on federal grants
Obriy Solution: Tailored U.S. corporate structures & waiver strategies.Resulting Advantage: Access to DARPA, BARDA, and DIU funding, even for foreign-parented teams.
Geopolitical competition (Chinese components, supply-chain risks)
Obriy Solution: Legislative language substituting adversarial tech with Ukrainian alternatives.Resulting Advantage: Locked-in demand for UA-made solutions.
Three Levels of Impact
Clients
Colmatek
Colmatek is a medtech startup developing next-generation hemostatic technologies that help surgeons and first responders stop bleeding faster, safer, and more efficiently.
Mark Wealth
Mark is an AI-powered wellness assistant designed to support employee health, prevent burnout, and optimize supplement usage.
Svarmed
Svarmed is a low-temperature bio-welding device that joins tissue without sutures or staples, resulting in faster patient recovery and reduced hospital costs.
Ready to build, fund, and defend the next generation of Ukrainian tech in the United States? Obriy is always open to new projects and fresh ideas, turning vision into reality and empowering innovation to thrive on a global stage.